Lantheus Holdings, Inc. (LNTH) stock
LNTHNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 11/3012% above fair value
$102.00+0.20 (+0.20%)
Close on Nov 18, 2026Market cap $6.66BP/E 24.7Yield –
Lantheus shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Lantheus's shares outstanding was 68M at Jun 30, 2026. For fiscal 2025 it was 68M, down 4.5% from the year before. Over ten years it grew 10.8% a year on average. The highest annual figure on record is 18.03B in fiscal 2013.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 68M | -4.5% |
| FY2024 | Dec 31, 2024 | 72M | +2.0% |
| FY2023 | Dec 31, 2023 | 70M | -0.6% |
| FY2022 | Dec 31, 2022 | 71M | +4.7% |
| FY2021 | Dec 31, 2021 | 67M | +24.7% |
| FY2020 | Dec 31, 2020 | 54M | +35.0% |
| FY2019 | Dec 31, 2019 | 40M | +1.5% |
| FY2018 | Dec 31, 2018 | 40M | +1.6% |
| FY2017 | Dec 31, 2017 | 39M | +19.1% |
| FY2016 | Dec 31, 2016 | 33M | +33.6% |
| FY2015 | Dec 31, 2015 | 24M | +35.2% |
| FY2014 | Dec 31, 2014 | 18M | -99.9% |
| FY2013 | Dec 31, 2013 | 18.03B | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 68M | -4.0% |
| Q1 FY2026 | Mar 31, 2026 | 66M | -8.0% |
| Q4 FY2025 | Dec 31, 2025 | 67M | -8.2% |
| Q3 FY2025 | Sep 30, 2025 | 68M | -7.4% |
| Q2 FY2025 | Jun 30, 2025 | 70M | -0.4% |
| Q1 FY2025 | Mar 31, 2025 | 71M | +1.9% |
| Q4 FY2024 | Dec 31, 2024 | 73M | +3.5% |
| Q3 FY2024 | Sep 30, 2024 | 73M | +4.3% |
| Q2 FY2024 | Jun 30, 2024 | 71M | -0.6% |
| Q1 FY2024 | Mar 31, 2024 | 70M | +3.5% |
| Q4 FY2023 | Dec 31, 2023 | 70M | -0.7% |
| Q3 FY2023 | Sep 30, 2023 | 70M | -1.4% |
| Q2 FY2023 | Jun 30, 2023 | 71M | +0.3% |
| Q1 FY2023 | Mar 31, 2023 | 68M | -3.3% |
| Q4 FY2022 | Dec 31, 2022 | 71M | +4.4% |
| Q3 FY2022 | Sep 30, 2022 | 71M | +5.1% |
| Q2 FY2022 | Jun 30, 2022 | 71M | +4.9% |
| Q1 FY2022 | Mar 31, 2022 | 70M | +3.5% |
| Q4 FY2021 | Dec 31, 2021 | 68M | +1.1% |
| Q3 FY2021 | Sep 30, 2021 | 68M | +1.2% |
| Q2 FY2021 | Jun 30, 2021 | 68M | +56.5% |
| Q1 FY2021 | Mar 31, 2021 | 68M | +68.9% |
| Q4 FY2020 | Dec 31, 2020 | 67M | +67.1% |
| Q3 FY2020 | Sep 30, 2020 | 67M | +65.9% |
| Q2 FY2020 | Jun 30, 2020 | 43M | +7.2% |
| Q1 FY2020 | Mar 31, 2020 | 40M | +0.8% |
| Q4 FY2019 | Dec 31, 2019 | 40M | +1.2% |
| Q3 FY2019 | Sep 30, 2019 | 40M | +2.2% |
| Q2 FY2019 | Jun 30, 2019 | 40M | +2.1% |
| Q1 FY2019 | Mar 31, 2019 | 40M | +0.7% |
| Q4 FY2018 | Dec 31, 2018 | 40M | +2.5% |
| Q3 FY2018 | Sep 30, 2018 | 39M | +0.7% |
| Q2 FY2018 | Jun 30, 2018 | 39M | +1.3% |
| Q1 FY2018 | Mar 31, 2018 | 39M | +2.3% |
| Q4 FY2017 | Dec 31, 2017 | 39M | +3.1% |
| Q3 FY2017 | Sep 30, 2017 | 39M | +20.7% |
| Q2 FY2017 | Jun 30, 2017 | 39M | – |
| Q1 FY2017 | Mar 31, 2017 | 39M | – |
| Q4 FY2016 | Dec 31, 2016 | 37M | – |
| Q3 FY2016 | Sep 30, 2016 | 32M | – |
See a number that looks wrong?